contract achizitii medicamente de uz uman
4 suppliers awarded•359 lots awarded•€2.39M awarded
Buyer: Centrul Medical de Diagnostic, Tratament Ambulatoriu si Medicina Preventiva - Bucuresti / Bucuresti, Romania
Awarded value
€2.39M
Estimated value
€2.39M
Awarded at 100% of estimated value
Award date
Apr 21, 2024
Winners
4
Lots awarded
359
Award values
Notice total
€2.39M
Sum of lot awards
€18.70M
TED notice total and lot-level values do not exactly match.
Winners
Bucuresti, ROU
€75,833 This contract
594 award notices•1,987 awarded lots•€333.14M total
Ghimbav, ROU
€19,905 This contract
670 award notices•1,848 awarded lots•€140.63M total
Lots awarded
| Lot | Title | Winner | Award value | Main CPV |
|---|---|---|---|---|
| LOT-0183 | Framework | Not specified | €3.3M | Agents acting on the renin-angiotensin system (33622800) |
| LOT-0184 | Framework | Not specified | €1.4M | Anaesthetics (33661100) |
| LOT-0235 | Framework | Not specified | €1.3M | Vasoprotectives (33622400) |
| LOT-0048 | Framework | Not specified | €1.2M | Perfusion solutions (33692400) |
| LOT-0111 | Framework | Not specified | €1.0M | Agents acting on the renin-angiotensin system (33622800) |
| LOT-0115 | Framework | Not specified | €763,504 | Antithrombotic agents (33621100) |
| LOT-0047 | Framework | Not specified | €620,564 | General anti-infectives for systemic use and vaccines (33651000) |
| LOT-0109 | Framework | Not specified | €534,153 | Medicinal products for functional gastrointestinal disorders (33612000) |
| LOT-0208 | Framework | Not specified | €436,187 | Anaesthetics (33661100) |
| LOT-0037 | Framework | Not specified | €404,011 | Anaesthetics (33661100) |
| LOT-0032 | Framework | Not specified | €368,640 | Injectable solutions (33692500) |
| LOT-0177 | Framework | Not specified | €362,882 | Injectable solutions (33692500) |
| LOT-0234 | Framework | Not specified | €279,881 | Anaesthetics (33661100) |
| LOT-0101 | Framework | Not specified | €241,516 | Cardiac therapy medicinal products (33622100) |
| LOT-0099 | Framework | Not specified | €237,158 | Injectable solutions (33692500) |
| LOT-0098 | Framework | Not specified | €225,148 | Anti-inflammatory and anti-rheumatic products (33632100) |
| LOT-0186 | Framework | Not specified | €215,109 | Perfusion solutions (33692400) |
| LOT-0108 | Framework | Not specified | €183,486 | Medicinal products for functional gastrointestinal disorders (33612000) |
| LOT-0110 | Framework | Not specified | €180,817 | Medicinal products for the genitourinary system and hormones (33640000) |
| LOT-0085 | Framework | Not specified | €167,870 | Injectable solutions (33692500) |
| LOT-0151 | Framework | Not specified | €166,166 | Anaesthetics (33661100) |
| LOT-0174 | Framework | Not specified | €163,616 | Injectable solutions (33692500) |
| LOT-0187 | Framework | Not specified | €156,266 | Perfusion solutions (33692400) |
| LOT-0086 | Framework | Not specified | €152,837 | Vasoprotectives (33622400) |
| LOT-0100 | Framework | Not specified | €120,760 | Anti-inflammatory and anti-rheumatic products (33632100) |
| LOT-0029 | Framework | Not specified | €119,368 | Medicinal products for sensory organs (33662000) |
| LOT-0182 | Framework | Not specified | €118,592 | Agents acting on the renin-angiotensin system (33622800) |
| LOT-0116 | Framework | Not specified | €108,625 | Antithrombotic agents (33621100) |
| LOT-0189 | Framework | Not specified | €93,778 | Perfusion solutions (33692400) |
| LOT-0046 | Framework | Not specified | €84,836 | Various medicinal products (33690000) |
| LOT-0252 | Framework | Not specified | €84,513 | Analgesics (33661200) |
| LOT-0105 | Framework | Not specified | €79,936 | Medicinal products for functional gastrointestinal disorders (33612000) |
| LOT-0238 | Framework | Not specified | €76,396 | Beta-blocking agents (33622600) |
| LOT-0149 | Framework | Not specified | €73,975 | Anaesthetics (33661100) |
| LOT-0190 | Framework | Not specified | €68,143 | Perfusion solutions (33692400) |
| LOT-0191 | Framework | Not specified | €63,026 | Beta-blocking agents (33622600) |
| LOT-0218 | Framework | Not specified | €62,310 | Agents acting on the renin-angiotensin system (33622800) |
| LOT-0237 | Framework | Not specified | €59,877 | Vasoprotectives (33622400) |
| LOT-0143 | Framework | Not specified | €59,827 | Perfusion solutions (33692400) |
| LOT-0134 | Framework | Not specified | €59,780 | Various medicinal products (33690000) |
| LOT-0253 | Framework | Not specified | €59,028 | Analgesics (33661200) |
| LOT-0077 | Framework | Not specified | €56,867 | Agents acting on the renin-angiotensin system (33622800) |
| LOT-0196 | Framework | Not specified | €56,867 | Ophthalmologicals (33662100) |
| LOT-0173 | Framework | Not specified | €51,698 | Medicinal products for functional gastrointestinal disorders (33612000) |
| LOT-0269 | Framework | FARMEXIM S.A. | €49,460 | Antianaemic preparations (33621300) |
| LOT-0097 | Framework | Not specified | €49,349 | Antihistamines for systemic use (33675000) |
| LOT-0107 | Framework | Not specified | €48,485 | Medicinal products for functional gastrointestinal disorders (33612000) |
| LOT-0039 | Framework | Not specified | €47,843 | Agents acting on the renin-angiotensin system (33622800) |
| LOT-0271 | Framework | Not specified | €45,990 | Perfusion solutions (33692400) |
| LOT-0278 | Framework | Not specified | €45,360 | Antianaemic preparations (33621300) |
| LOT-0026 | Framework | Not specified | €44,286 | Anaesthetics (33661100) |
| LOT-0244 | Framework | Not specified | €42,113 | Agents acting on the renin-angiotensin system (33622800) |
| LOT-0022 | Framework | Not specified | €41,254 | Vasoprotectives (33622400) |
| LOT-0136 | Framework | Not specified | €40,824 | Anaesthetics (33661100) |
| LOT-0088 | Framework | Not specified | €40,681 | Vasoprotectives (33622400) |
| LOT-0146 | Framework | Not specified | €40,108 | Perfusion solutions (33692400) |
| LOT-0049 | Framework | Not specified | €39,573 | General anti-infectives for systemic use and vaccines (33651000) |
| LOT-0145 | Framework | Not specified | €39,535 | Perfusion solutions (33692400) |
| LOT-0114 | Framework | Not specified | €38,389 | Agents acting on the renin-angiotensin system (33622800) |
| LOT-0229 | Framework | Not specified | €38,183 | Vasoprotectives (33622400) |
| LOT-0279 | Framework | Not specified | €37,243 | Antianaemic preparations (33621300) |
| LOT-0170 | Framework | Not specified | €37,004 | Medicinal products for functional gastrointestinal disorders (33612000) |
| LOT-0242 | Framework | Not specified | €36,145 | Agents acting on the renin-angiotensin system (33622800) |
| LOT-0027 | Framework | Not specified | €34,760 | Injectable solutions (33692500) |
| LOT-0139 | Framework | Not specified | €34,225 | Diuretics (33622300) |
| LOT-0276 | Framework | Not specified | €32,086 | Antianaemic preparations (33621300) |
| LOT-0118 | Framework | Not specified | €31,513 | Injectable solutions (33692500) |
| LOT-0266 | Framework | Not specified | €27,502 | Antianaemic preparations (33621300) |
| LOT-0074 | Framework | Not specified | €27,374 | Medicinal products for obstructive airway diseases (33673000) |
| LOT-0282 | Framework | Not specified | €26,929 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0028 | Framework | Not specified | €26,738 | Antibiotics and chemotherapeutics for dermatological use (33631400) |
| LOT-0291 | Framework | Not specified | €26,738 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0078 | Framework | Not specified | €26,471 | Diuretics (33622300) |
| LOT-0247 | Framework | Not specified | €26,070 | Medicinal products for obstructive airway diseases (33673000) |
| LOT-0256 | Framework | Not specified | €25,900 | Cardiac therapy medicinal products (33622100) |
| LOT-0246 | Framework | Not specified | €25,669 | Psychoanaleptics (33661600) |
| LOT-0075 | Framework | Not specified | €25,263 | Agents acting on the renin-angiotensin system (33622800) |
| LOT-0035 | Framework | Not specified | €25,211 | Beta-blocking agents (33622600) |
| LOT-0267 | Framework | Not specified | €25,211 | Antianaemic preparations (33621300) |
| LOT-0043 | Framework | Not specified | €25,076 | Agents acting on the renin-angiotensin system (33622800) |
| LOT-0284 | Framework | Not specified | €25,070 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0221 | Framework | Not specified | €24,638 | Injectable solutions (33692500) |
| LOT-0195 | Framework | Not specified | €24,494 | Ophthalmologicals (33662100) |
| LOT-0205 | Framework | FARMEXIM S.A. | €24,301 | Vasoprotectives (33622400) |
| LOT-0268 | Framework | Not specified | €24,301 | Antianaemic preparations (33621300) |
| LOT-0119 | Framework | Not specified | €23,396 | Medicinal products for obstructive airway diseases (33673000) |
| LOT-0219 | Framework | Not specified | €23,062 | Agents acting on the renin-angiotensin system (33622800) |
| LOT-0164 | Framework | Not specified | €22,903 | Anaesthetics (33661100) |
| LOT-0050 | Framework | DR.MAX | €22,436 | General anti-infectives for systemic use and vaccines (33651000) |
| LOT-0274 | Framework | Not specified | €22,436 | Vitamins (33616000) |
| LOT-0228 | Framework | Not specified | €22,059 | Vasoprotectives (33622400) |
| LOT-0133 | Framework | Not specified | €21,658 | Various medicinal products (33690000) |
| LOT-0168 | Framework | Not specified | €21,486 | Perfusion solutions (33692400) |
| LOT-0175 | Framework | Not specified | €20,913 | Various medicinal products (33690000) |
| LOT-0188 | Framework | Not specified | €20,627 | Perfusion solutions (33692400) |
| LOT-0233 | Framework | Not specified | €19,767 | Medicinal products for obstructive airway diseases (33673000) |
| LOT-0227 | Framework | Not specified | €19,624 | Vasoprotectives (33622400) |
| LOT-0239 | Framework | Not specified | €19,338 | Diuretics (33622300) |
| LOT-0275 | Framework | Not specified | €19,252 | Vitamins (33616000) |
| LOT-0030 | Framework | Not specified | €19,099 | Medicinal products for sensory organs (33662000) |
| LOT-0283 | Framework | Not specified | €18,852 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0013 | Framework | Not specified | €18,481 | Injectable solutions (33692500) |
| LOT-0251 | Framework | FRESENIUS KABI ROMANIA | €18,383 | Analgesics (33661200) |
| LOT-0299 | Framework | Not specified | €18,383 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0014 | Framework | Not specified | €18,182 | Cardiac therapy medicinal products (33622100) |
| LOT-0156 | Framework | Not specified | €18,144 | Cardiac therapy medicinal products (33622100) |
| LOT-0194 | Framework | Not specified | €18,048 | General anti-infectives for systemic use and vaccines (33651000) |
| LOT-0106 | Framework | Not specified | €17,861 | Injectable solutions (33692500) |
| LOT-0294 | Framework | Not specified | €17,810 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0181 | Framework | Not specified | €17,478 | Medicinal products for obstructive airway diseases (33673000) |
| LOT-0138 | Framework | Not specified | €17,036 | Agents acting on the renin-angiotensin system (33622800) |
| LOT-0040 | Framework | Not specified | €16,960 | Agents acting on the renin-angiotensin system (33622800) |
| LOT-0167 | Framework | Not specified | €16,330 | Perfusion solutions (33692400) |
| LOT-0243 | Framework | Not specified | €15,757 | Agents acting on the renin-angiotensin system (33622800) |
| LOT-0180 | Framework | Not specified | €15,545 | Various medicinal products (33690000) |
| LOT-0192 | Framework | Not specified | €14,897 | Vasoprotectives (33622400) |
| LOT-0127 | Framework | Not specified | €14,873 | Calcium channel blockers (33622700) |
| LOT-0132 | Framework | Not specified | €14,840 | Mineral supplements (33617000) |
| LOT-0258 | Framework | Not specified | €14,840 | General anti-infectives for systemic use and vaccines (33651000) |
| LOT-0042 | Framework | Not specified | €14,778 | Agents acting on the renin-angiotensin system (33622800) |
| LOT-0157 | Framework | Not specified | €14,663 | Anti-inflammatory and anti-rheumatic products (33632100) |
| LOT-0126 | Framework | Not specified | €14,587 | Calcium channel blockers (33622700) |
| LOT-0226 | Framework | Not specified | €14,396 | Vasoprotectives (33622400) |
| LOT-0031 | Framework | Not specified | €14,324 | Injectable solutions (33692500) |
| LOT-0263 | Framework | Not specified | €14,324 | Psycholeptics (33661500) |
| LOT-0257 | Framework | Not specified | €14,181 | Ophthalmologicals (33662100) |
| LOT-0295 | Framework | Not specified | €14,038 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0185 | Framework | Not specified | €13,923 | Perfusion solutions (33692400) |
| LOT-0006 | Framework | Not specified | €13,904 | Provitamins (33616100) |
| LOT-0264 | Framework | Not specified | €13,861 | Psycholeptics (33661500) |
| LOT-0197 | Framework | Not specified | €13,751 | Medicinal products for acid related disorders (33611000) |
| LOT-0033 | Framework | Not specified | €13,560 | Antithrombotic agents (33621100) |
| LOT-0166 | Framework | Not specified | €13,465 | Anaesthetics (33661100) |
| LOT-0297 | Framework | Not specified | €13,465 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0036 | Framework | Not specified | €13,422 | Anaesthetics (33661100) |
| LOT-0286 | Framework | Not specified | €13,064 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0076 | Framework | Not specified | €13,057 | Agents acting on the renin-angiotensin system (33622800) |
| LOT-0083 | Framework | Not specified | €12,997 | Ophthalmologicals (33662100) |
| LOT-0082 | Framework | Not specified | €12,968 | Ophthalmologicals (33662100) |
| LOT-0079 | Framework | Not specified | €12,801 | Agents acting on the renin-angiotensin system (33622800) |
| LOT-0024 | Framework | Not specified | €12,295 | Vasoprotectives (33622400) |
| LOT-0220 | Framework | Not specified | €12,032 | Agents acting on the renin-angiotensin system (33622800) |
| LOT-0038 | Framework | Not specified | €11,933 | Mineral supplements (33617000) |
| LOT-0056 | Framework | Not specified | €11,848 | Antithrombotic agents (33621100) |
| LOT-0065 | Framework | Not specified | €11,631 | Medicinal products for obstructive airway diseases (33673000) |
| LOT-0103 | Framework | Not specified | €11,459 | Calcium channel blockers (33622700) |
| LOT-0158 | Framework | Not specified | €11,459 | Anti-inflammatory and anti-rheumatic products (33632100) |
| LOT-0241 | Framework | Not specified | €11,101 | Medicinal products for the genitourinary system and hormones (33640000) |
| LOT-0053 | Framework | Not specified | €10,987 | General anti-infectives for systemic use and vaccines (33651000) |
| LOT-0225 | Framework | Not specified | €10,743 | Injectable solutions (33692500) |
| LOT-0207 | Framework | Not specified | €10,625 | Agents acting on the renin-angiotensin system (33622800) |
| LOT-0025 | Framework | Not specified | €10,027 | Vasoprotectives (33622400) |
| LOT-0094 | Framework | Not specified | €10,027 | Perfusion solutions (33692400) |
| LOT-0245 | Framework | Not specified | €9,740 | Medicinal products for obstructive airway diseases (33673000) |
| LOT-0073 | Framework | Not specified | €9,597 | Medicinal products for obstructive airway diseases (33673000) |
| LOT-0055 | Framework | Not specified | €9,549 | Antithrombotic agents (33621100) |
| LOT-0240 | Framework | Not specified | €9,203 | Antithrombotic agents (33621100) |
| LOT-0280 | Framework | Not specified | €9,167 | Antianaemic preparations (33621300) |
| LOT-0159 | Framework | Not specified | €8,881 | Calcium channel blockers (33622700) |
| LOT-0011 | Framework | Not specified | €8,833 | Psycholeptics (33661500) |
| LOT-0212 | Framework | Not specified | €8,726 | Various medicinal products (33690000) |
| LOT-0095 | Framework | Not specified | €8,272 | Anti-inflammatory and anti-rheumatic products (33632100) |
| LOT-0213 | Framework | Not specified | €8,182 | Various medicinal products (33690000) |
| LOT-0217 | Framework | Not specified | €8,165 | Injectable solutions (33692500) |
| LOT-0287 | Framework | Not specified | €8,122 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0054 | Framework | Not specified | €8,022 | General anti-infectives for systemic use and vaccines (33651000) |
| LOT-0230 | Framework | Not specified | €7,878 | Vasoprotectives (33622400) |
| LOT-0135 | Framework | Not specified | €7,854 | Various medicinal products (33690000) |
| LOT-0092 | Framework | Not specified | €7,834 | Anaesthetics (33661100) |
| LOT-0289 | Framework | Not specified | €7,824 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0259 | Framework | Not specified | €7,821 | General anti-infectives for systemic use and vaccines (33651000) |
| LOT-0117 | Framework | Not specified | €7,764 | Injectable solutions (33692500) |
| LOT-0096 | Framework | Not specified | €7,759 | Anti-inflammatory and anti-rheumatic products (33632100) |
| LOT-0290 | Framework | Not specified | €7,620 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0007 | Framework | Not specified | €7,598 | Provitamins (33616100) |
| LOT-0216 | Framework | Not specified | €7,563 | Injectable solutions (33692500) |
| LOT-0081 | Framework | Not specified | €7,520 | Medicinal products for obstructive airway diseases (33673000) |
| LOT-0004 | Framework | Not specified | €7,492 | Medicinal products for dermatology (33631000) |
| LOT-0120 | Framework | Not specified | €7,449 | Medicinal products for acid related disorders (33611000) |
| LOT-0161 | Framework | Not specified | €7,219 | Antihistamines for systemic use (33675000) |
| LOT-0148 | Framework | Not specified | €7,143 | Perfusion solutions (33692400) |
| LOT-0215 | Framework | Not specified | €7,105 | Injectable solutions (33692500) |
| LOT-0067 | Framework | Not specified | €7,019 | Agents acting on the renin-angiotensin system (33622800) |
| LOT-0288 | Framework | Not specified | €7,009 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0018 | Framework | Not specified | €6,952 | Various medicinal products (33690000) |
| LOT-0015 | Framework | Not specified | €6,708 | Calcium channel blockers (33622700) |
| LOT-0150 | Framework | Not specified | €6,601 | Anaesthetics (33661100) |
| LOT-0113 | Framework | Not specified | €6,406 | Agents acting on the renin-angiotensin system (33622800) |
| LOT-0068 | Framework | Not specified | €6,231 | Calcium channel blockers (33622700) |
| LOT-0131 | Framework | Not specified | €5,844 | Anaesthetics (33661100) |
| LOT-0162 | Framework | Not specified | €5,730 | General anti-infectives for systemic use and vaccines (33651000) |
| LOT-0206 | Framework | Not specified | €5,706 | Agents acting on the renin-angiotensin system (33622800) |
| LOT-0060 | Framework | SC PHARMA SA | €5,500 | Agents acting on the renin-angiotensin system (33622800) |
| LOT-0272 | Framework | Not specified | €5,500 | Other therapeutic products (33693000) |
| LOT-0093 | Framework | Not specified | €5,491 | Various medicinal products (33690000) |
| LOT-0222 | Framework | Not specified | €5,415 | Injectable solutions (33692500) |
| LOT-0104 | Framework | Not specified | €5,372 | Anti-inflammatory and anti-rheumatic products (33632100) |
| LOT-0199 | Framework | Not specified | €5,357 | Medicinal products for functional gastrointestinal disorders (33612000) |
| LOT-0057 | Framework | Not specified | €5,300 | Medicinal products for the musculo-skeletal system (33632000) |
| LOT-0254 | Framework | Not specified | €5,157 | Analgesics (33661200) |
| LOT-0169 | Framework | Not specified | €5,013 | Perfusion solutions (33692400) |
| LOT-0020 | Framework | Not specified | €4,942 | Vasoprotectives (33622400) |
| LOT-0016 | Framework | Not specified | €4,775 | Calcium channel blockers (33622700) |
| LOT-0172 | Framework | Not specified | €4,727 | Various medicinal products (33690000) |
| LOT-0265 | Framework | Not specified | €4,727 | Perfusion solutions (33692400) |
| LOT-0142 | Framework | Not specified | €4,684 | Injectable solutions (33692500) |
| LOT-0198 | Framework | Not specified | €4,627 | Medicinal products for acid related disorders (33611000) |
| LOT-0236 | Framework | Not specified | €4,584 | Vasoprotectives (33622400) |
| LOT-0203 | Framework | Not specified | €4,431 | Injectable solutions (33692500) |
| LOT-0122 | Framework | Not specified | €4,412 | Injectable solutions (33692500) |
| LOT-0293 | Framework | Not specified | €4,369 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0171 | Framework | Not specified | €4,297 | Injectable solutions (33692500) |
| LOT-0001 | Framework | Not specified | €4,011 | Antithrombotic agents (33621100) |
| LOT-0063 | Framework | Not specified | €4,011 | Medicinal products for obstructive airway diseases (33673000) |
| LOT-0129 | Framework | Not specified | €3,977 | Vasoprotectives (33622400) |
| LOT-0102 | Framework | Not specified | €3,940 | Injectable solutions (33692500) |
| LOT-0008 | Framework | Not specified | €3,762 | Antigout preparations (33632300) |
| LOT-0160 | Framework | Not specified | €3,724 | Calcium channel blockers (33622700) |
| LOT-0261 | Framework | Not specified | €3,677 | Agents acting on the renin-angiotensin system (33622800) |
| LOT-0017 | Framework | Not specified | €3,509 | General anti-infectives for systemic use and vaccines (33651000) |
| LOT-0069 | Framework | Not specified | €3,409 | Calcium channel blockers (33622700) |
| LOT-0193 | Framework | Not specified | €3,342 | Cardiac therapy medicinal products (33622100) |
| LOT-0003 | Framework | Not specified | €3,309 | Medicinal products for the alimentary tract and metabolism (33610000) |
| LOT-0200 | Framework | Not specified | €3,242 | Medicinal products for acid related disorders (33611000) |
| LOT-0071 | Framework | Not specified | €3,111 | Medicinal products for obstructive airway diseases (33673000) |
| LOT-0165 | Framework | Not specified | €3,056 | Anaesthetics (33661100) |
| LOT-0281 | Framework | Not specified | €3,056 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0034 | Framework | Not specified | €3,008 | Antithrombotic agents (33621100) |
| LOT-0124 | Framework | Not specified | €3,008 | Anti-inflammatory and anti-rheumatic products (33632100) |
| LOT-0041 | Framework | Not specified | €2,906 | Agents acting on the renin-angiotensin system (33622800) |
| LOT-0121 | Framework | Not specified | €2,841 | Medicinal products for acid related disorders (33611000) |
| LOT-0155 | Framework | Not specified | €2,834 | Anaesthetics (33661100) |
| LOT-0002 | Framework | Not specified | €2,774 | Various medicinal products (33690000) |
| LOT-0210 | Framework | DR.MAX | €2,695 | Medicinal products for sensory organs (33662000) |
| LOT-0277 | Framework | Not specified | €2,695 | Antianaemic preparations (33621300) |
| LOT-0140 | Framework | Not specified | €2,692 | Diuretics (33622300) |
| LOT-0019 | Framework | Not specified | €2,674 | Various medicinal products (33690000) |
| LOT-0125 | Framework | Not specified | €2,674 | Anti-inflammatory and anti-rheumatic products (33632100) |
| LOT-0232 | Framework | Not specified | €2,674 | Vasoprotectives (33622400) |
| LOT-0201 | Framework | Not specified | €2,620 | Medicinal products for acid related disorders (33611000) |
| LOT-0066 | Framework | Not specified | €2,578 | Medicinal products for acid related disorders (33611000) |
| LOT-0255 | Framework | Not specified | €2,540 | Analgesics (33661200) |
| LOT-0009 | Framework | Not specified | €2,343 | Antigout preparations (33632300) |
| LOT-0176 | Framework | Not specified | €2,268 | Various medicinal products (33690000) |
| LOT-0178 | Framework | Not specified | €2,244 | Various medicinal products (33690000) |
| LOT-0064 | Framework | Not specified | €2,208 | Medicinal products for obstructive airway diseases (33673000) |
| LOT-0211 | Framework | Not specified | €2,126 | Various medicinal products (33690000) |
| LOT-0130 | Framework | Not specified | €2,087 | Anaesthetics (33661100) |
| LOT-0270 | Framework | FARMEXIM S.A. | €2,072 | Antianaemic preparations (33621300) |
| LOT-0052 | Framework | Not specified | €2,034 | General anti-infectives for systemic use and vaccines (33651000) |
| LOT-0051 | Framework | Not specified | €2,029 | General anti-infectives for systemic use and vaccines (33651000) |
| LOT-0090 | Framework | Not specified | €2,005 | Various medicinal products (33690000) |
| LOT-0141 | Framework | Not specified | €2,005 | Medicinal products for sensory organs (33662000) |
| LOT-0044 | Framework | Not specified | €1,948 | Agents acting on the renin-angiotensin system (33622800) |
| LOT-0250 | Framework | Not specified | €1,939 | Ophthalmologicals (33662100) |
| LOT-0062 | Framework | Not specified | €1,886 | Various medicinal products (33690000) |
| LOT-0128 | Framework | Not specified | €1,881 | Vasoprotectives (33622400) |
| LOT-0058 | Framework | Not specified | €1,767 | Corticosteroids for dermatological use and dermatological preparations (33631500) |
| LOT-0249 | Framework | Not specified | €1,623 | Ophthalmologicals (33662100) |
| LOT-0112 | Framework | Not specified | €1,604 | Injectable solutions (33692500) |
| LOT-0163 | Framework | Not specified | €1,604 | Anaesthetics (33661100) |
| LOT-0273 | Framework | FRESENIUS KABI ROMANIA | €1,522 | Vitamins (33616000) |
| LOT-0080 | Framework | Not specified | €1,464 | Agents acting on the renin-angiotensin system (33622800) |
| LOT-0091 | Framework | Not specified | €1,432 | Various medicinal products (33690000) |
| LOT-0223 | Framework | Not specified | €1,432 | Injectable solutions (33692500) |
| LOT-0144 | Framework | Not specified | €1,415 | Perfusion solutions (33692400) |
| LOT-0147 | Framework | Not specified | €1,415 | Perfusion solutions (33692400) |
| LOT-0214 | Framework | Not specified | €1,396 | Medicinal products for sensory organs (33662000) |
| LOT-0010 | Framework | Not specified | €1,297 | Psycholeptics (33661500) |
| LOT-0123 | Framework | Not specified | €1,289 | Anti-inflammatory and anti-rheumatic products (33632100) |
| LOT-0292 | Framework | Not specified | €1,241 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0209 | Framework | Not specified | €1,218 | Anaesthetics (33661100) |
| LOT-0087 | Framework | Not specified | €1,194 | Vasoprotectives (33622400) |
| LOT-0285 | Framework | Not specified | €1,098 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0012 | Framework | Not specified | €1,085 | Psycholeptics (33661500) |
| LOT-0021 | Framework | Not specified | €1,022 | Vasoprotectives (33622400) |
| LOT-0061 | Framework | Not specified | €984 | Agents acting on the renin-angiotensin system (33622800) |
| LOT-0202 | Framework | Not specified | €979 | Injectable solutions (33692500) |
| LOT-0153 | Framework | Not specified | €955 | Agents acting on the renin-angiotensin system (33622800) |
| LOT-0179 | Framework | Not specified | €955 | Anaesthetics (33661100) |
| LOT-0296 | Framework | Not specified | €919 | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0084 | Framework | Not specified | €907 | Analgesics (33661200) |
| LOT-0260 | Framework | Not specified | €899 | Medicinal products for obstructive airway diseases (33673000) |
| LOT-0059 | Framework | Not specified | €859 | Agents acting on the renin-angiotensin system (33622800) |
| LOT-0072 | Framework | Not specified | €774 | Medicinal products for obstructive airway diseases (33673000) |
| LOT-0248 | Framework | Not specified | €764 | Medicinal products for obstructive airway diseases (33673000) |
| LOT-0152 | Framework | Not specified | €752 | Diuretics (33622300) |
| LOT-0089 | Framework | Not specified | €723 | Various medicinal products (33690000) |
| LOT-0005 | Framework | Not specified | €696 | Medicinal products for the musculo-skeletal system (33632000) |
| LOT-0045 | Framework | Not specified | €664 | Injectable solutions (33692500) |
| LOT-0070 | Framework | Not specified | €587 | Calcium channel blockers (33622700) |
| LOT-0023 | Framework | Not specified | €560 | Vasoprotectives (33622400) |
| LOT-0137 | Framework | Not specified | €525 | Agents acting on the renin-angiotensin system (33622800) |
| LOT-0204 | Framework | Not specified | €460 | Various medicinal products (33690000) |
| LOT-0231 | Framework | Not specified | €297 | Vasoprotectives (33622400) |
| LOT-0224 | Framework | Not specified | €296 | Injectable solutions (33692500) |
| LOT-0154 | Framework | Not specified | €196 | Agents acting on the renin-angiotensin system (33622800) |
| LOT-0262 | Framework | Not specified | €191 | Agents acting on the renin-angiotensin system (33622800) |
| LOT-0298 | Framework | Not specified | — | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0300 | Framework | Not specified | — | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0301 | Framework | Not specified | — | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0302 | Framework | Not specified | — | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0303 | Framework | Not specified | — | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0304 | Framework | Not specified | — | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0305 | Framework | Not specified | — | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0306 | Framework | Not specified | — | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0307 | Framework | Not specified | — | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0308 | Framework | Not specified | — | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0309 | Framework | Not specified | — | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0310 | Framework | Not specified | — | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0311 | Framework | Not specified | — | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0312 | Framework | Not specified | — | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0313 | Framework | Not specified | — | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0314 | Framework | Not specified | — | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0315 | Framework | Not specified | — | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0316 | Framework | Not specified | — | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0317 | Framework | Not specified | — | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0318 | Framework | Not specified | — | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0319 | Framework | Not specified | — | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0320 | Framework | Not specified | — | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0321 | Framework | Not specified | — | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0322 | Framework | Not specified | — | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0323 | Framework | Not specified | — | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0324 | Framework | Not specified | — | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0325 | Framework | Not specified | — | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0326 | Framework | Not specified | — | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0327 | Framework | Not specified | — | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0328 | Framework | Not specified | — | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0329 | Framework | Not specified | — | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0330 | Framework | Not specified | — | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0331 | Framework | Not specified | — | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0332 | Framework | Not specified | — | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0333 | Framework | Not specified | — | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0334 | Framework | Not specified | — | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0335 | Framework | Not specified | — | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0336 | Framework | Not specified | — | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0337 | Framework | Not specified | — | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0338 | Framework | Not specified | — | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0339 | Framework | Not specified | — | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0340 | Framework | Not specified | — | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0341 | Framework | Not specified | — | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0342 | Framework | Not specified | — | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0343 | Framework | Not specified | — | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0344 | Framework | Not specified | — | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0345 | Framework | Not specified | — | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0346 | Framework | Not specified | — | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0347 | Framework | Not specified | — | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0348 | Framework | Not specified | — | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0349 | Framework | Not specified | — | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0350 | Framework | Not specified | — | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0351 | Framework | Not specified | — | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0352 | Framework | Not specified | — | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0353 | Framework | Not specified | — | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0354 | Framework | Not specified | — | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0355 | Framework | Not specified | — | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0356 | Framework | Not specified | — | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0357 | Framework | Not specified | — | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0358 | Framework | Not specified | — | Antineoplastic and immunomodulating agents (33652000) |
| LOT-0359 | Framework | Not specified | — | Antineoplastic and immunomodulating agents (33652000) |